-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Cognition Therapeutics Inc quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2023.
- Cognition Therapeutics Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$14.5M, a 1.91% increase year-over-year.
- Cognition Therapeutics Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$58.4M, a 30.3% decline year-over-year.
- Cognition Therapeutics Inc annual Operating Income (Loss) for 2023 was -$50.7M, a 16.5% decline from 2022.
- Cognition Therapeutics Inc annual Operating Income (Loss) for 2022 was -$43.6M, a 52.3% decline from 2021.
- Cognition Therapeutics Inc annual Operating Income (Loss) for 2021 was -$28.6M, a 64.3% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)